Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 25237 | 239 | 40.3 | 89% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 705 | 12205 | MATRIX METALLOPROTEINASES//CD147//MATRIX METALLOPROTEINASE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MODIFIED TETRACYCLINE | Author keyword | 2 | 67% | 1% | 2 |
| 2 | IMPERIAL WELLCOME TRUST CLIN TROP MED | Address | 1 | 100% | 1% | 2 |
| 3 | MAZANKOWSKI ALBERTA HEART PHARMACOL | Address | 1 | 100% | 1% | 2 |
| 4 | HERITAGE MED 4 62 | Address | 1 | 20% | 2% | 4 |
| 5 | CALPONIN 1 | Author keyword | 1 | 33% | 1% | 2 |
| 6 | ASTROCYLE | Author keyword | 1 | 50% | 0% | 1 |
| 7 | CLIN VET SCI ORAL PATHOL | Address | 1 | 50% | 0% | 1 |
| 8 | EXUDATIVE EFFUSION | Author keyword | 1 | 50% | 0% | 1 |
| 9 | FIBROUS TALC | Author keyword | 1 | 50% | 0% | 1 |
| 10 | HLTH NIHR P BIOMED UNIT | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MODIFIED TETRACYCLINE | 2 | 67% | 1% | 2 | Search MODIFIED+TETRACYCLINE | Search MODIFIED+TETRACYCLINE |
| 2 | CALPONIN 1 | 1 | 33% | 1% | 2 | Search CALPONIN+1 | Search CALPONIN+1 |
| 3 | ASTROCYLE | 1 | 50% | 0% | 1 | Search ASTROCYLE | Search ASTROCYLE |
| 4 | EXUDATIVE EFFUSION | 1 | 50% | 0% | 1 | Search EXUDATIVE+EFFUSION | Search EXUDATIVE+EFFUSION |
| 5 | FIBROUS TALC | 1 | 50% | 0% | 1 | Search FIBROUS+TALC | Search FIBROUS+TALC |
| 6 | MATRIX META METALLOPROTEINASE | 1 | 50% | 0% | 1 | Search MATRIX+META+METALLOPROTEINASE | Search MATRIX+META+METALLOPROTEINASE |
| 7 | MMP 9 GELATINASE B | 1 | 50% | 0% | 1 | Search MMP+9+GELATINASE+B | Search MMP+9+GELATINASE+B |
| 8 | RAPC | 1 | 50% | 0% | 1 | Search RAPC | Search RAPC |
| 9 | VASCULAR HYPOCONTRACTILITY | 1 | 50% | 0% | 1 | Search VASCULAR+HYPOCONTRACTILITY | Search VASCULAR+HYPOCONTRACTILITY |
| 10 | DT 2 | 0 | 33% | 0% | 1 | Search DT+2 | Search DT+2 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | REGULATES MATRIX METALLOPROTEINASE 1 | 5 | 63% | 2% | 5 |
| 2 | MATRIX METALLOPROTEINASE 1 POLYMORPHISM | 1 | 100% | 1% | 2 |
| 3 | CHAPERONIN 602 | 1 | 50% | 0% | 1 |
| 4 | GELATINASE B DEFICIENCY | 1 | 50% | 0% | 1 |
| 5 | GELATINASE EXPRESSION | 1 | 50% | 0% | 1 |
| 6 | HM 3 | 1 | 50% | 0% | 1 |
| 7 | MONOCYTE NETWORKS | 1 | 50% | 0% | 1 |
| 8 | LETHAL HEPATITIS | 1 | 29% | 1% | 2 |
| 9 | TIMP 1 PRODUCTION | 0 | 13% | 1% | 3 |
| 10 | 2 ACE2 | 0 | 33% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Serum MMP-8,-9 and TIMP-1 in sepsis: High serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines | 2011 | 25 | 30 | 30% |
| Matrix Metalloproteinases as Drug Targets in Infections Caused by Gram-Negative Bacteria and in Septic Shock | 2009 | 47 | 148 | 20% |
| The paradox of matrix metalloproteinases in infectious disease | 2005 | 124 | 110 | 16% |
| Matrix metalloproteases and their association to tuberculosis | 2010 | 1 | 26 | 50% |
| Tackling tissue destruction in tuberculosis | 2008 | 1 | 5 | 40% |
| Repair after acute lung injury: molecular mechanisms and therapeutic opportunities | 2012 | 7 | 40 | 13% |
| Matrix Metalloproteinases in Respiratory Diseases: From Pathogenesis to Potential Clinical Implications | 2009 | 25 | 194 | 13% |
| Matrix metalloproteinases as modulators of inflammation and innate immunity | 2004 | 744 | 139 | 3% |
| Matrix metalloproteinases in pneumonia | 2014 | 0 | 68 | 13% |
| Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? | 2002 | 32 | 107 | 7% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IMPERIAL WELLCOME TRUST CLIN TROP MED | 1 | 100% | 0.8% | 2 |
| 2 | MAZANKOWSKI ALBERTA HEART PHARMACOL | 1 | 100% | 0.8% | 2 |
| 3 | HERITAGE MED 4 62 | 1 | 20% | 1.7% | 4 |
| 4 | CLIN VET SCI ORAL PATHOL | 1 | 50% | 0.4% | 1 |
| 5 | HLTH NIHR P BIOMED UNIT | 1 | 50% | 0.4% | 1 |
| 6 | MAZANKOWSKI ALBERTA HEART PEDIAT | 1 | 50% | 0.4% | 1 |
| 7 | ORGAN BIOPOLYMER CHEM | 1 | 50% | 0.4% | 1 |
| 8 | PULM CRIT CARE MEDBUSAN PAIK HOSP | 1 | 50% | 0.4% | 1 |
| 9 | CLIN URINARY TRACT INFECT | 0 | 33% | 0.4% | 1 |
| 10 | JOHNS HOPKINS TB | 0 | 33% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000193835 | SB 3CT//HEAD SHAKE RESPONSE//BBB BREAKDOWN |
| 2 | 0.0000122413 | MORPHOL ESTOMATOL PHYSIOL//2K 1C HYPERTENSION//MED IPB HSL |
| 3 | 0.0000121741 | MT1 MMP//CANC CELL//MMP 2 |
| 4 | 0.0000102583 | TUMOR TISSUE PROGRESSION//FIBROBLAST COLLAGENASE//CARRAGEENAN GRANULOMA |
| 5 | 0.0000093024 | MINOCYCLINE//CHEMICALLY MODIFIED TETRACYCLINES//ORAL BIOL PATHOL |
| 6 | 0.0000080332 | TIMP 1//SORSBYS FUNDUS DYSTROPHY//SORSBY FUNDUS DYSTROPHY |
| 7 | 0.0000076997 | ANESTHET//APOPTOSIS INHIBITOR 5//AAC 11 |
| 8 | 0.0000076388 | BCG//TUBERCULOSIS//LANZHOU TB |
| 9 | 0.0000070212 | EVOLUTIONARY IMMUNOBIOL//PERITONEAL INFLAMMATION//EVOLUT IMMUNOBIOL |
| 10 | 0.0000066926 | BLEOMYCIN//PULMONARY FIBROSIS//LUNG FIBROSIS |